91  Total SME IPOs listed in 2025

4,041.09 Crs.  Total funds raised in 2025

63  SME IPOs listed with Gain in 2025

28  SME IPOs listed with loss in 2025

91  Total SME IPOs listed in 2025

4,041.09 Crs.  Total funds raised in 2025

63  SME IPOs listed with Gain in 2025

28  SME IPOs listed with loss in 2025

91  Total SME IPOs listed in 2025

4,041.09 Crs.  Total funds raised in 2025

63  SME IPOs listed with Gain in 2025

28  SME IPOs listed with loss in 2025

91  Total SME IPOs listed in 2025

4041.09 Crs.  Total funds raised in 2,025.00

63  SME IPOs listed with Gain in 2025

28  SME IPOs listed with loss in 2025

Global Health Limited IPO Analysis

Global Health IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 2205.57 Cr. The company is based in New Delhi and caters to Healthcare - Hospitals And Clinic sector. Credit Suisse Securities (India) , Jefferies India , Jm Financial , Kotak Mahindra Capital Company are the merchant bankers of Global Health IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th September 2021.

Global Health IPO posted revenues of ₹ 2506.16 crores and PAT of ₹ 234.84 crores in FY23 on annualised basis.

IPO Key Highlights

*At the time of IPO, on Annualised Basis
  • Revenue: ₹ 2,468.84 Cr.
            EBITDA: ₹ 566.56 Cr.
            PAT: ₹ 234.84 Cr.
  • EBITDA Margin: 22.95 %
            Pat Margin: 9.51 %
  • Net Worth: ₹ 1675.55 Cr.
  • Market Capitalisation: ₹ 9011.01 Cr.
  • P/E: 38.36 times
  • P/BV: 2.32 times
  • EV/EBITDA: 17.09 times
Nature of IPO : MainBoard
Exchange : BSE,NSE
IPO Type : Book Building

Global Health IPO Financial Performance (Restated)

Financial results of Global Health IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.

Amount in ₹ crores
Financials Jun-22 FY22 FY21 FY20
Balance Sheet
Assets 3221.94 3145.52 2694.10 2666.29
Net Worth 1675.55 1616.01 1382.34 1349.54
Total Debt 794.45 837.86 644.60 621.94
Profit & Loss
Revenue
Revenue on annualised basis
617.21
2,468.84
2166.59 1446.74 1500.42
EBITDA
EBITDA on annualised basis
141.64
566.56
489.76 222.85 230.45
PAT
PAT on annualised basis
58.71
234.84
196.20 28.80 36.33
Financials
30-Jun-22
FY22
FY21
FY20
Balance Sheet
Assets
3221.94
3145.52
2694.10
2666.29

Net Worth
1675.55
1616.01
1382.34
1349.54

Total Debt
794.45
837.86
644.60
621.94

Profit & Loss
Revenue
Revenue on annualised basis
617.21
2,468.84
2166.59
1446.74
1500.42

EBITDA
EBITDA on annualised basis
141.64
566.56
489.76
222.85
230.45

PAT
PAT on annualised basis
58.71
234.84
196.20
28.80
36.33

Notes:
1) Total debt incluides long-term borrowings and short-term borrowings.
2) Revenue means the Revenue from Operations as appearing in the Restated Financial Statements.

Global Health IPO Key performance Indicators (KPI)

Global Health IPO PAT Margin is 9.51 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Global Health IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.

Particulars Jun-22 FY22 FY21 FY20
EBITDA Margin (%) 22.95 22.61 15.40 15.36
PAT Margin (%) 9.51 9.06 1.99 2.42
EPS (₹) 2.32 7.78 1.15 1.45
ROE (%) 3.50 12.14 2.08 2.69
ROCE (%) [●] [●] [●] [●]
ROA (%) 1.82 6.24 1.07 1.36
Debt to Equity 0.47 0.52 0.47 0.46
Particulars
30-Jun-22
FY22
FY21
FY20

EBITDA Margin (%)
22.95
22.61
15.40
15.36

PAT Margin (%)
9.51
9.06
1.99
2.42

EPS (₹)
2.32
7.78
1.15
1.45

ROE (%)
3.50
12.14
2.08
2.69

ROCE (%)
[●]
[●]
[●]
[●]

ROA (%)
1.82
6.24
1.07
1.36

Debt to Equity (x)  
0.47
0.52
0.47
0.46

Notes:
1) The EPS represents post-bonus basic EPS.
2) Return on Equity is ratio of Profit after Tax and Total Equity.
3) Return on Assets is ratio of Profit after Tax and Total Assets.
4) Debt to Equity is ratio of Total borrowings and Total Equity.

Global Health IPO Valuation Metrics

The market Capitalisation of Global Health IPO is ₹ 9011.01 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.

Key Metrics (at the time of IPO)


Market Capitalisation (₹ Cr.):
9011.01

Enterprise Value (EV) (₹ Cr.):
9,685.02

EV/EBITDA (times) :
17.09

PE Multiple (times) :
38.36

P/B (times) :
2.32

NAV (₹) :
66.17

Notes:
1) The Enterprise Value is calculated as Market Cap. + Total Debt - Cash and Cash Equivalents.
2) Price to Book multiple is calculated as the ratio of Market Cap. and Net Worth post IPO proceeds.

What are the key financial metrics in Global Health prospectus?

The Global Health IPO prospectus highlights an Return on Equity (ROE) of 3.50 % , Return on Assets (ROA) of 1.82 %, and an EBITDA Margin of 22.95 %, showcasing financial performance.

How do profitability ratios impact the evaluation of Global Health IPO?

Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Global Health IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.

What is the market capitalisation for Global Health IPO ?

The post-IPO market capitalisation of Global Health IPO is ₹ 9011.01 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.

What is the PE Multiple of Global Health IPO?

The Global Health IPO has a Price-to-Earnings (PE) ratio of 38.36 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.

What is the Revenue of Global Health IPO?

Global Health IPO reported revenue of ₹ 2506.16 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Global Health IPO provide insights into sales growth, market demand, and business scalability.

What is the EBITDA of Global Health IPO?

Global Health recorded an EBITDA of ₹ 566.56 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.

What is the PAT of Global Health IPO?

Global Health Profit After Tax (PAT) is ₹ 234.84 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions

IPO Key Highlights

*At the time of IPO, on Annualised Basis
  • Revenue: ₹ 2,468.84 Cr.
            EBITDA: ₹ 566.56 Cr.
            PAT: ₹ 234.84 Cr.
  • EBITDA Margin: 22.95 %
            Pat Margin: 9.51 %
  • Net Worth: ₹ 1675.55 Cr.
  • Market Capitalisation: ₹ 9011.01 Cr.
  • P/E: 38.36 times
  • P/BV: 2.32 times
  • EV/EBITDA: 17.09 times

Revenue

(As Annualised)

EBITDA

(As Annualised)

PAT

(As Annualised)
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

Recent IPO List

Kalpataru Limited

  Real Estate

  Mumbai


Ellenbarrie Industrial Gases Limited

  Oil and Gas

  Kolkata


Globe Civil Projects Limited

  Engineering - EPC

  New Delhi


Aris Infra Solutions Limited

  Infrastructure

  Mumbai


Oswal Pumps Limited

  Solar

  Karnal


Peer Companies Of This Sector

FAQs

Global Health operates in Healthcare - Hospitals And Clinic and Multi-speciality Healthcare Centre Operating. The Issue is listed on BSE,NSE in Nov, 2022. Global Health IPO size was 2205.57 with Issue price of 336.00 .

Merchant Banker(s) of Global Health IPO: Credit Suisse Securities (India) Private Limited , Jefferies India Private Limited , Jm Financial Limited , Kotak Mahindra Capital Company Limited

Global Health IPO subscription was 9.58 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Global Health IPO listed at a listing price of 415.65 against the offer price of 336.00.

The current market price of Global Health is 1151.40.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency